Uremic toxins: some thoughts on acrolein and spermine
Related Experiment Video
Updated: Mar 13, 2026

Production of Disulfide-stabilized Transmembrane Peptide Complexes for Structural Studies
Published on: March 6, 2013
1a Warren Alpert School of Medicine at Brown University , Providence , RI , USA.
Insights
Uremic toxins contribute to cardiovascular risks in chronic kidney disease (CKD). Recent findings suggest acrolein, not spermine, is the primary toxin responsible for these adverse effects in CKD patients.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Toxicology
Background:
- Chronic kidney disease (CKD) involves reduced glomerular filtration and uremic toxin accumulation.
- CKD patients face elevated cardiovascular mortality risk, inadequately explained by traditional risk factors.
- Uremic toxins are implicated as a key factor in CKD-related cardiovascular complications.
Purpose of the Study:
- To review recent literature on the role of spermine and its derivatives as uremic toxins.
- To clarify the specific uremic toxin responsible for cardiovascular risks in CKD.
- To re-evaluate the hypothesis of spermine as a significant uremic toxin.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of studies investigating uremic toxins and cardiovascular outcomes in CKD.
- Examination of the metabolic pathways and toxicological profiles of spermine and acrolein.
Main Results:
- Evidence casts doubt on spermine's role as a primary uremic toxin.
- Acrolein, an oxidative product of spermine and spermidine, is identified as a likely uremic toxin.
- Acrolein may account for toxic effects previously attributed to spermine.
Conclusions:
- Acrolein, rather than spermine, is likely responsible for the cardiovascular toxicity associated with uremic toxins in CKD.
- This finding necessitates a re-evaluation of therapeutic strategies targeting uremic toxins in chronic kidney disease management.
Abstract:
Chronic kidney disease (CKD) is characterized by the progressive reduction of glomerular filtration rate and subsequent retention of organic waste compounds called uremic toxins. While patients with CKD are at a higher risk of premature death due to cardiovascular complications, this increased risk cannot be completely explained by classical cardiovascular risk factors such as hypertension, diabetes mellitus, and obesity. Instead, recent research suggests that uremic toxins may play a key role in explaining this marked increase in cardiovascular mortality in patients with CKD. While spermine, a tetra-amine, has previously been hypothesized to act as an uremic toxin, the following review presents a summary of recent literature that casts doubt on this assertion. Instead, acrolein, an oxidative product of spermine and the triamine spermidine, is likely responsible for the toxic effects previously attributed to spermine.
More Related Videos
07:03Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury
Published on: February 15, 2022
09:23Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability
Published on: June 21, 2015
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Prevention of Further Absorption of Poison
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...